Osatek
Osakidetza Organization
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublications in collaboration with researchers from Ikerbasque, Fundación Vasca para la Ciencia (16)
2023
2022
-
Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)
Scientific Reports
-
Heart-brain synchronization breakdown in Parkinson’s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
-
Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
Journal of Neurology
2021
-
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Frontiers in Medicine, Vol. 8
-
Contributions of sex, depression, and cognition on brain connectivity dynamics in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1
2020
-
Brain connectivity and cognitive functioning in individuals six months after multiorgan failure
NeuroImage: Clinical, Vol. 25
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
Scientific Reports, Vol. 10, Núm. 1
-
Neurodegeneration trajectory in pediatric and adult/late DM1: A follow-up MRI study across a decade
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1802-1815
2019
-
Liquid biopsy in glioblastoma: Opportunities, applications and challenges
Cancers, Vol. 11, Núm. 7
2018
-
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
Scientific Reports, Vol. 8, Núm. 1
2016
-
MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 4, pp. 393-405
-
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery
Surgery for Obesity and Related Diseases, Vol. 12, Núm. 10, pp. 1838-1846
-
Targeting SOX2 as a therapeutic strategy in glioblastoma
Frontiers in Oncology
2014
2013
-
Therapeutic strategies targeting Glioblastoma stem cells
Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 216-227